'Why I feel bad': Refinement of the effects of prostate cancer upon lifestyle questionnaire and an initial exploration of its links with anxiety and depression among prostate cancer patients

Christopher F. Sharpley, Vicki Bitsika, David R H Christie

Research output: Contribution to journalArticleResearchpeer-review

21 Citations (Scopus)

Abstract

Objective: To psychometrically refine a standardized scale for identifying those lifestyle changes that were most likely to contribute to anxiety and depression among prostate cancer (PCa) patients. Methods: Three hundred and eighty-one PCa patients who had received their initial diagnosis between one and 96 months completed a survey of background variables, anxiety and depression inventories and the 36-item Effects of Prostate Cancer upon Lifestyle Questionnaire (EPCLQ). Results: Levels of anxiety (24%) and depression (26%) were similar to those previously reported for PCa patients. The EPCLQ was shown to have satisfactory psychometric properties and significantly predicted anxiety and depression scores and the presence of psychological clinicity among this sample. Factor analysis of the EPCLQ showed that adverse emotions and social withdrawal, plus loss of cognitive ability, were the most powerful predictors of fear, physiological arousal, discomfort and pain factors underlying anxiety; these factors also predicted pessimism and fatigue factors underlying depression. Conclusions: The EPCLQ was shown to be a reliably sound and valid instrument for assessing important lifestyle changes that predict anxiety and depression among PCa patients. In addition, links between receiving a diagnosis and treatment for PCa and development of psychosocial disturbance via emotional negativity, decreased cognitive performance and withdrawal from others appear to warrant further investigation.

Original languageEnglish
Pages (from-to)839-846
Number of pages8
JournalPsycho-Oncology
Volume19
Issue number8
DOIs
Publication statusPublished - Aug 2010

Fingerprint

Life Style
Prostatic Neoplasms
Anxiety
Depression
Surveys and Questionnaires
Aptitude
Arousal
Psychometrics
Statistical Factor Analysis
Fear
Fatigue
Emotions
Psychology
Pain
Equipment and Supplies

Cite this

@article{28e4b99b3bee4c1dbd7abcf2b676d7bd,
title = "'Why I feel bad': Refinement of the effects of prostate cancer upon lifestyle questionnaire and an initial exploration of its links with anxiety and depression among prostate cancer patients",
abstract = "Objective: To psychometrically refine a standardized scale for identifying those lifestyle changes that were most likely to contribute to anxiety and depression among prostate cancer (PCa) patients. Methods: Three hundred and eighty-one PCa patients who had received their initial diagnosis between one and 96 months completed a survey of background variables, anxiety and depression inventories and the 36-item Effects of Prostate Cancer upon Lifestyle Questionnaire (EPCLQ). Results: Levels of anxiety (24{\%}) and depression (26{\%}) were similar to those previously reported for PCa patients. The EPCLQ was shown to have satisfactory psychometric properties and significantly predicted anxiety and depression scores and the presence of psychological clinicity among this sample. Factor analysis of the EPCLQ showed that adverse emotions and social withdrawal, plus loss of cognitive ability, were the most powerful predictors of fear, physiological arousal, discomfort and pain factors underlying anxiety; these factors also predicted pessimism and fatigue factors underlying depression. Conclusions: The EPCLQ was shown to be a reliably sound and valid instrument for assessing important lifestyle changes that predict anxiety and depression among PCa patients. In addition, links between receiving a diagnosis and treatment for PCa and development of psychosocial disturbance via emotional negativity, decreased cognitive performance and withdrawal from others appear to warrant further investigation.",
author = "Sharpley, {Christopher F.} and Vicki Bitsika and Christie, {David R H}",
year = "2010",
month = "8",
doi = "10.1002/pon.1623",
language = "English",
volume = "19",
pages = "839--846",
journal = "Psycho-Oncology",
issn = "1057-9249",
publisher = "Wiley Blackwell (American Society Bone & Mineral Research)",
number = "8",

}

'Why I feel bad' : Refinement of the effects of prostate cancer upon lifestyle questionnaire and an initial exploration of its links with anxiety and depression among prostate cancer patients. / Sharpley, Christopher F.; Bitsika, Vicki; Christie, David R H.

In: Psycho-Oncology, Vol. 19, No. 8, 08.2010, p. 839-846.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - 'Why I feel bad'

T2 - Refinement of the effects of prostate cancer upon lifestyle questionnaire and an initial exploration of its links with anxiety and depression among prostate cancer patients

AU - Sharpley, Christopher F.

AU - Bitsika, Vicki

AU - Christie, David R H

PY - 2010/8

Y1 - 2010/8

N2 - Objective: To psychometrically refine a standardized scale for identifying those lifestyle changes that were most likely to contribute to anxiety and depression among prostate cancer (PCa) patients. Methods: Three hundred and eighty-one PCa patients who had received their initial diagnosis between one and 96 months completed a survey of background variables, anxiety and depression inventories and the 36-item Effects of Prostate Cancer upon Lifestyle Questionnaire (EPCLQ). Results: Levels of anxiety (24%) and depression (26%) were similar to those previously reported for PCa patients. The EPCLQ was shown to have satisfactory psychometric properties and significantly predicted anxiety and depression scores and the presence of psychological clinicity among this sample. Factor analysis of the EPCLQ showed that adverse emotions and social withdrawal, plus loss of cognitive ability, were the most powerful predictors of fear, physiological arousal, discomfort and pain factors underlying anxiety; these factors also predicted pessimism and fatigue factors underlying depression. Conclusions: The EPCLQ was shown to be a reliably sound and valid instrument for assessing important lifestyle changes that predict anxiety and depression among PCa patients. In addition, links between receiving a diagnosis and treatment for PCa and development of psychosocial disturbance via emotional negativity, decreased cognitive performance and withdrawal from others appear to warrant further investigation.

AB - Objective: To psychometrically refine a standardized scale for identifying those lifestyle changes that were most likely to contribute to anxiety and depression among prostate cancer (PCa) patients. Methods: Three hundred and eighty-one PCa patients who had received their initial diagnosis between one and 96 months completed a survey of background variables, anxiety and depression inventories and the 36-item Effects of Prostate Cancer upon Lifestyle Questionnaire (EPCLQ). Results: Levels of anxiety (24%) and depression (26%) were similar to those previously reported for PCa patients. The EPCLQ was shown to have satisfactory psychometric properties and significantly predicted anxiety and depression scores and the presence of psychological clinicity among this sample. Factor analysis of the EPCLQ showed that adverse emotions and social withdrawal, plus loss of cognitive ability, were the most powerful predictors of fear, physiological arousal, discomfort and pain factors underlying anxiety; these factors also predicted pessimism and fatigue factors underlying depression. Conclusions: The EPCLQ was shown to be a reliably sound and valid instrument for assessing important lifestyle changes that predict anxiety and depression among PCa patients. In addition, links between receiving a diagnosis and treatment for PCa and development of psychosocial disturbance via emotional negativity, decreased cognitive performance and withdrawal from others appear to warrant further investigation.

UR - http://www.scopus.com/inward/record.url?scp=77955151817&partnerID=8YFLogxK

U2 - 10.1002/pon.1623

DO - 10.1002/pon.1623

M3 - Article

VL - 19

SP - 839

EP - 846

JO - Psycho-Oncology

JF - Psycho-Oncology

SN - 1057-9249

IS - 8

ER -